Cell line · CVCL_0528
SK-N-BE(2)
Cancer cell line, Homo sapiens. Neuroblastoma. 56 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SK-N-BE(2). Cell lines, record CVCL_0528. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0528
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-N-BE(2)
- Accession
- CVCL_0528
- RRID
- RRID:CVCL_0528
- Synonyms
- SK-N-BE2, SK-N-BE-2, SKNBE(2), SKNBE-2, SKNBE2, SK-N-BE, SKNBE
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 2Y2M
- Category
- Cancer cell line
- Diseases
- Neuroblastoma (NCIt C3270); Neuroblastoma (ORDO Orphanet_635)
- Derived from
- Bone marrow (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers56
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PP2A Activation as a Senotherapeutic in Neuroblastoma. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Neuronal differentiation of neuroblastoma cell lines for neurological disease modeling. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Irinotecan Modulates Immune Checkpoints in Neuroblastoma. | Immunotargets Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NDUFS6 promotes neuroblastoma progression and represents a potential therapeutic target. | Transl Pediatr | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 45A ncRNA Expression Leads to Chromosomal Instability and Cytoskeletal Dynamics Impairment by Modulating GTSE1/p53/AurB Subcellular Localization. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi‑omics identification of MSI2 as a super-enhancer‑driven vulnerability in MYCN‑amplified neuroblastoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Towards a unified molecular mechanism for ligand-dependent activation of NR4A-RXR heterodimers. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| QW-5-70 Targets the Colchicine Site and Demonstrates Antitumor Activity in P-gp-Overexpressing Cancer Models. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in Neuroblastoma. | Clin Transl Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 56
See all 56 papersRelatives4
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abcam SK-N-BE(2) GRM5 KO | CVCL_B0ZE | Cell lines | |
| Derived from it | SK-N-BE(2)-C | CVCL_0529 | Cell lines | |
| Derived from it | SK-N-BE(2)-M17 | CVCL_0167 | Cell lines | |
| From the same person | SK-N-BE(1) | CVCL_9898 | Cell lines |
Cell banks9
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-2271 | ATCC | |
| Abcam | ab275476 | Discontinued | Cellosaurus |
| BCRJ | 0381 | BCRJ | |
| CLS | 305058 | CLS | |
| CancerTools | 161921 | CancerTools | |
| DSMZ | ACC-632 | DSMZ | |
| ECACC | 95011815 | ECACC | |
| ICLC | HTL96015 | ICLC | |
| KCB | KCB 2011099YJ | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0528
GET https://conductscience.org/api/cell-lines/v1/CVCL_0528/papers?page=2